HIGHLIGHTS
- who: Adela Brahimaj from the Department of Epidemiology, Erasmus University Medical Center, , CA Rotterdam, The Netherlands have published the Article: Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study, in the Journal: (JOURNAL)
- what: The authors aimed to identify novel inflammatory markers that predict progression from normoglycemia to pre-diabetes incident T2D and insulin therapy. The authors investigated a wide range of inflammatory markers for phase-specific prediction of progression to type 2 DM and identified EN-RAGE, IL13 and IL17 as novel inflammatory markers. This study has certain strengths . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.